Illuminating Breast Cancer Recurrence Risk  |   > Search     |   Take me to: Oncotype - Home Healthcare Professionals - Home Oncotype DX Logistics - Home About Oncotype DX About Recurrence Oncotype DX Development Health Insurance Coverage Frequently Asked Questions Glossary Helpful Links About Oncotype DX What is Oncotype DX? Who is Oncotype DX For? How is Oncotype DX Performed? How Can Oncotype DX Benefit Me? Oncotype DX Results How Do I Get a Test? About Recurrence Oncotype DX Development Health Insurance Coverage Frequently Asked Questions Glossary Helpful Links What is Oncotype DX? Oncotype DX® is a diagnostic test that quantifies the likelihood of disease recurrence in women with early stage breast cancer and assesses the likely benefit from chemotherapy.1 With this information, it may be possible for doctors and patients to make more informed decisions about breast cancer treatment options. Oncotype DX analyzes a specific set of genes within a tumor to determine a Recurrence Score®.The Recurrence Score is a number between 0 and 100 that corresponds to a specific likelihood of breast cancer recurrence within 10 years of the initial diagnosis. To learn more about the Recurrence Score, click here. Click here to view an animation of how Oncotype DX works. Make a selection below to download the Oncotype DX process animation. For PC users, once the download is complete double-click on the file to uncompress it and double-click on oncotype_demo.exe to run the animation. For Mac users, once the download is complete simply click on the desktop icon. PC Download Mac Download 1 The data on chemotherapy benefit is derived from the NSABP Study B-20 which compared hormonal therapy alone versus CMF based chemotherapy and hormonal therapy. What's New? November 11, 2008 Genomic Health to Present at Stephens Fall Investment Conference November 10, 2008 Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated

© 2008 Genomic Health, Inc.  All rights reserved. | Home | Contact Us | Privacy | Terms and Conditions |